January11th,2021By Mel J. YeatesModerna COVID-19 vaccine gains nod from UKThe MHRA has granted temporary authorization for the use of the company’s mRNA-based vaccine
January11th,2021By Mel J. YeatesEverlywell signs distribution agreement with Ginkgo BioworksEverlywell will distribute FDA-authorized rapid antigen testing for organizations and public health agencies
January11th,2021By DDN StaffIdentifying structural variants in COVID-19Bionano’s Saphyr system helps identify structural variants with possible roles in pathogenesis and outcomes in COVID-19
Other Internal MedicineJanuary7th,2021By DDN StaffA metagenomics meetupCareDx, IDbyDNA strike up partnership for infectious disease testing in transplant patients
January6th,2021By Mel J. YeatesHIV vaccine candidate VIR1111 enters Phase 1Vir Biotechnology initiates Phase 1 trial to evaluate a novel HIV vaccine platform
January5th,2021By DDN Staff (from GlobalData)The easy way inWide adoption and regimen compliance are two reasons for easier administration, whether with COVID or schizophrenia
January5th,2021By Randall C WillisOut of order: A season of hopeSharing insights, stories, progress, and hope on fighting infectious diseases
January5th,2021By Jeffrey BouleyGoodbye DDNews; hello DDNWith our first issue of 2021, we have lots of great changes to bring you
DiscoveryJanuary4th,2021By Mel J. YeatesChoosing CRISPR in the fight against SARS-CoV-2Study demonstrates how changes in human genes can reduce SARS-CoV-2 infection